In both cell lines and patient-derived material, RelA NF-κB site-binding was over two-fold higher in ABC-DLBCL samples, whereas c-Rel NF-κB site-binding was over two-fold higher in GCB-DLBCL samples [132]. This evidence concerns the gene NFKB1 and diffuse large B-cell lymphoma.